Lv33
340 积分 2025-04-11 加入
Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease
6小时前
已完结
Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD)
8小时前
已完结
Targeting PPARs for therapy of atherosclerosis: A review
10天前
已完结
Drugs targeting peroxisome proliferator-activated receptors
10天前
已完结
Risks of Stroke Recurrence and Mortality After First and Recurrent Strokes in Denmark
22天前
已完结
Burden and Long term Trends of Stroke in China: Based on GBD 1990-2021
22天前
已完结
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
1个月前
已完结
Pharmacokinetics, pharmacodynamics, safety, and tolerability of hyzetimibe (HS-25) in healthy Chinese subjects
3个月前
已完结
New Insights Into the Importance of Dietary Cholesterol in Preventing Cardiovascular Disease
3个月前
已关闭
Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention
4个月前
已关闭
皖公网安备34019202002308
